Amanote Research
Register
Sign In
223. The Biochemical and Functional Effects of Spontaneous Deamidation of the AAV Capsid on Gene Therapy Vectors
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)35236-4
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2014
Authors
Unknown
Publisher
Elsevier BV
Related search
Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors
Molecular Therapy - Methods and Clinical Development
Molecular Medicine
Genetics
Molecular Biology
Capsid-Expressing DNA in AAV Vectors and Its Elimination by Use of an Oversize Capsid Gene for Vector Production
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Effects of Spontaneous Deamidation on the Cytotoxic Activity of theBacillus anthracisProtective Antigen
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
310. Development of Generation X Recombinant AAV Vectors for Human Gene Therapy
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
221. The Utilization of Capsid-Optimized Adeno-Associated Virus (AAV) Vectors for Cancer Immunotherapy
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
309. Optimization of Dual AAV Vectors for Gene Therapy of Inherited Retinal Diseases
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
308. Inclusion of Heterologous ITRs in Dual AAV Vectors for Retinal Gene Therapy
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Developing Immunologically Inert Adeno-Associated Virus (AAV) Vectors for Gene Therapy: Possibilities and Limitations
Current Pharmaceutical Biotechnology
Biotechnology
Pharmaceutical Science
Production and Characterization of Vectors Based on the Cardiotropic AAV Serotype 9
Methods in Molecular Biology
Genetics
Molecular Biology
